Benefits
Bulk sugar replacement with zero glycemic impact
About 60-70% as sweet as sucrose with near-zero calorie content (commonly labeled as 0.2-0.5 kcal/g). Glycemic index near zero — does not raise blood glucose or insulin. Bulk-replacement properties (similar volume to sugar) make it useful in baking and beverages where high-intensity sweeteners alone don't provide texture.
Safety signal: higher blood erythritol linked to more heart attacks and strokes
In a 2023 Nature Medicine study, people with the highest blood erythritol were about 1.8 times more likely (2,149 US patients) and about 2.2 times more likely (833 European patients) to have a heart attack, stroke or death over 3 years than those with the lowest levels. Everyone in these groups was already being evaluated for heart disease, and this is an association, not proof that erythritol caused the events. One reason for caution in reading it: the body makes small amounts of erythritol on its own, more so in diabetes and obesity, so blood levels partly reflect underlying metabolic health. The same paper also found erythritol made platelets stickier in the laboratory and sped clotting in animals, and its authors called for long-term safety studies.
What a single 30 g dose did to blood levels in 8 people
In a pilot with only 8 healthy volunteers, a single 30 g dose raised blood erythritol sharply and kept it elevated for more than 2 days, well above the levels that made platelets more reactive in laboratory experiments. That is the opposite of returning to baseline within hours. The pilot measured blood levels, not clots or heart events, and 8 people is far too few to judge safety either way. Industry has argued that one large dose is not typical food exposure.
Endogenous production confounder
Erythritol is produced endogenously from glucose via the pentose phosphate pathway. Production is elevated in diabetes, obesity, and metabolic syndrome — the same conditions associated with cardiovascular risk. Suggests the observational cardiovascular signal may be partially driven by underlying metabolic state. This is a real limitation, but it does not explain everything: the reported risk figures were already statistically adjusted, and the platelet and animal clotting effects were produced by erythritol given from outside the body.
Regulatory status — currently unchanged
FDA Generally Recognized as Safe (GRAS) status maintained. EU EFSA approved. WHO non-sugar sweetener guidance includes erythritol with caution but no specific restriction. Industry responses to the recent findings emphasize dose context and the limits of observational data, while the researchers who reported the cardiovascular association concluded that studies of erythritol's long-term safety are warranted.
Better GI tolerance than other polyols
About 95% absorbed in the small intestine, then excreted unchanged in urine. Most polyols (sorbitol, xylitol, mannitol) cause osmotic diarrhea at much lower doses. Erythritol's GI threshold is roughly 50 g single dose versus 20 g for sorbitol. In practice that means most people can use it in sugar-free foods without the stomach upset other sugar alcohols cause.
Dental health — non-cariogenic
The main cavity-causing mouth bacteria cannot ferment erythritol, so it does not feed tooth decay. The only dental source cited on this page is a 2018 review in Advances in Dental Research, written by an industry-affiliated scientist, which concluded that erythritol is well tolerated, non-cariogenic, and may lower plaque and cavity risk. A review summarizes other people's work rather than testing anything, and erythritol's dental use is less well established than xylitol's.
Practical interpretation
Erythritol is still approved by regulators and is a genuinely calorie-free, blood-sugar-neutral way to replace sugar. The cardiovascular findings are unresolved rather than settled in either direction, and the researchers who reported them asked for long-term safety studies. A sensible approach: occasional use in foods is a different situation from stacking several erythritol-sweetened drinks and baked goods every day. If you have heart disease, a clotting disorder, or take blood thinners, talk with your doctor before using it heavily.
Mechanism of action
Small-intestine absorption and renal excretion
Erythritol is absorbed by passive diffusion across the small intestine at ~90% efficiency — unusually high for a polyol due to its small molecular size (4 carbons, MW 122). Once absorbed, humans lack the enzymatic machinery to metabolize erythritol; it circulates in plasma and is excreted essentially unchanged in urine within 24 hours. This non-metabolism is the basis for the ~0.2 kcal/g caloric value and the zero glycemic effect.
Endogenous synthesis via pentose phosphate pathway
Erythritol is produced endogenously from glucose-6-phosphate via the pentose phosphate pathway — particularly active during metabolic stress, hyperglycemia, and oxidative conditions. Plasma erythritol can be elevated in people with diabetes or obesity even without dietary erythritol intake. That makes blood erythritol an imperfect marker of what someone eats, which is an important limitation of the observational study. The 2023 paper's own 8-person pilot did show that eating 30 g pushes blood levels far above the amount the body makes on its own.
Platelet activation at observed plasma concentrations
In vitro experiments showed erythritol at concentrations achieved in patients with high dietary intake (low millimolar range) enhanced platelet aggregation in response to the body's normal clot-triggering signals. Mouse experiments showed faster clot formation in arterial injury models with elevated circulating erythritol. In an 8-person pilot, a 30 g oral dose raised blood erythritol far above normal and kept it there for more than 2 days, above the levels that increased platelet reactivity in the laboratory. The platelet and clotting findings themselves come from test-tube and animal work, not from a study measuring heart attacks in people.
Sweet taste and cooling mouthfeel
Erythritol activates the T1R2/T1R3 sweet taste receptor at lower potency than sucrose (~70% sweetness). Endothermic dissolution (erythritol absorbs heat as it dissolves) produces a distinctive cooling mouthfeel — useful in mints and chewing gum but often perceived as unpleasant in baked goods, prompting the use of stevia/monk fruit blends to reduce required erythritol mass.
Antioxidant properties (mechanistic interest, unclear clinical relevance)
In vitro studies have documented modest antioxidant activity for erythritol. This was historically cited as a positive feature but is mechanistically separate from — and does not offset — the platelet-activation findings. Antioxidant activity in a test tube does not prevent platelet aggregation in a human bloodstream.
Clinical trials
Three-cohort study from Cleveland Clinic Hazen lab.
Clinical population described in trial publication.
Three-cohort study from Cleveland Clinic Hazen lab. Untargeted metabolomics in 1,157 cardiac patients identified erythritol as a polyol sweetener associated with 3-year MACE (death, MI, stroke). Targeted validation in US (n=2,149, NCT00590200) and European (n=833, DRKS00020915) cohorts confirmed the association: highest vs. lowest plasma erythritol quartile adjusted hazard ratios were 1.80 (95% CI 1.18-2.77) and 2.21 (95% CI 1.20-4.07). In the same paper, erythritol made platelets more reactive in test-tube experiments and sped up clot formation in animals, which suggests a possible mechanism. Limitations: this is an observational association over 3 years of follow-up, not proof of cause, and everyone in these cohorts was already being evaluated for heart disease. The authors concluded that studies of erythritol's long-term safety are warranted. Funded by NIH NHLBI, ODS, and other agencies.
Prospective intervention in healthy volunteers comparing 30 g erythritol vs.
Clinical population described in trial publication.
This is not a separate trial. It is a small pilot inside the 2023 Nature Medicine paper: 8 healthy volunteers took 30 g of erythritol, and their blood erythritol rose markedly and stayed elevated for more than 2 days, well above the levels that increased platelet reactivity in that paper's laboratory experiments. The pilot measured blood levels, not clots or heart events, and 8 people cannot show whether erythritol causes cardiovascular harm. What it does show is that a single keto-sized serving pushes blood levels far outside the usual range, which is why the authors called for long-term safety studies.
Clinical trial in 485 first-grade children randomized to erythritol-, xylitol-, or sorbitol-sweetened candies for 3 years.
Clinical population described in trial publication.
Clinical trial in 485 first-grade children randomized to erythritol-, xylitol-, or sorbitol-sweetened candies for 3 years. Children in the erythritol group were reported to have fewer cavities than the xylitol or sorbitol groups. Important context: this study is not among the citations listed on this page, and the only dental source actually cited here is a 2018 review written by an industry-affiliated author. Treat the dental angle as supportive but secondary, and note that it says nothing about the cardiovascular findings.
Critical evaluation of the paper raising the endogenous-erythritol confounder argument.
Clinical population described in trial publication.
Critical evaluation of the paper raising the endogenous-erythritol confounder argument. Those authors agreed the original paper did not overstate its findings but argued that observational data alone cannot show that dietary erythritol causes harm. Note that this commentary is not among the four studies cited on this page, and no 2024 human trial is cited here to settle the question. What does exist is the 2023 paper's 8-person pilot showing that eating 30 g pushes blood erythritol far above the amount the body makes on its own, which weakens but does not remove the confounding concern.